B-cell clonality determination using an immunoglobulin kappa light chain polymerase chain reaction method

Area of Science:

• Molecular Biology
• Oncology
• Immunogenetics

Background:

• Clonality assessment is crucial for diagnosing B-cell malignancies.
• Existing methods, like immunoglobulin heavy chain (IgH) gene polymerase chain reaction (PCR), have limitations in sensitivity.
• Improved diagnostic tools are needed to accurately identify neoplastic B-cell populations.

Purpose of the Study:

• To develop and evaluate a consensus primer kappa light chain gene (Igkappa) PCR assay for augmenting B-cell malignancy detection.
• To assess the combined efficacy of Igkappa PCR and IgH PCR in identifying clonality.
• To introduce a novel chip-based capillary electrophoresis method for rapid analysis of PCR products.

Main Methods:

• Designed a consensus primer Igkappa PCR assay and combined it with a consensus primer IgH PCR assay.
• Evaluated the assays in 86 paraffin-embedded tissue samples of lymphoproliferations.
• Analyzed PCR products using native polyacrylamide gel electrophoresis and chip-based capillary electrophoresis.

Main Results:

• The Igkappa PCR assay detected clonality in 72% of mature B-cell neoplasms.
• Combined Igkappa/IgH PCR increased overall sensitivity from 81% to 90% compared to IgH PCR alone.
• Igkappa PCR was particularly effective in germinal center-related lymphomas.
• Sequencing revealed common Vkappa and Jkappa gene family involvement in rearrangements.

Conclusions:

• The Igkappa PCR assay effectively improves the detection rate of clonality in B-cell neoplasms.
• Combined Igkappa/IgH PCR offers enhanced sensitivity for diagnosing B-cell malignancies.
• Chip-based capillary electrophoresis provides a rapid method for PCR fragment size evaluation.